BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22013747)

  • 41. Sodium selenite protects against diabetes-induced alterations in the antioxidant defense system of the liver.
    Ayaz M; Celik HA; Aydin HH; Turan B
    Diabetes Metab Res Rev; 2006; 22(4):295-9. PubMed ID: 16285004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selenium altered the levels of lipids, lipid peroxidation, and sulfhydryl groups in straitum and thalamus of rat.
    Zia S; Islam F
    Biol Trace Elem Res; 2000 Dec; 77(3):251-9. PubMed ID: 11204467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of selenite treatment on ultrastructural changes in experimental diabetic rat bones.
    Ozdemir S; Ayaz M; Can B; Turan B
    Biol Trace Elem Res; 2005 Nov; 107(2):167-79. PubMed ID: 16217141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amelioration of cisplatin-induced nephrotoxicity by pravastatin in mice.
    An Y; Xin H; Yan W; Zhou X
    Exp Toxicol Pathol; 2011 Mar; 63(3):215-9. PubMed ID: 20060696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of mitochondria in NO-dependent regulation of Na+, K+ -ATP activity in the rat aorta].
    Akopova OV; Kotsiuruba AV; Kharlamova OM; Korkach IuP; Sahach VF
    Fiziol Zh (1994); 2010; 56(4):76-85. PubMed ID: 20968040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aqueous-ethanolic extract of morel mushroom mycelium Morchella esculenta, protects cisplatin and gentamicin induced nephrotoxicity in mice.
    Nitha B; Janardhanan KK
    Food Chem Toxicol; 2008 Sep; 46(9):3193-9. PubMed ID: 18692113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enzymatic studies of cisplatin induced oxidative stress in hepatic tissue of rats.
    Pratibha R; Sameer R; Rataboli PV; Bhiwgade DA; Dhume CY
    Eur J Pharmacol; 2006 Feb; 532(3):290-3. PubMed ID: 16458885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. alpha-Lipoic acid prevents cisplatin-induced acute kidney injury in rats.
    Bae EH; Lee J; Ma SK; Kim IJ; Frøkiaer J; Nielsen S; Kim SY; Kim SW
    Nephrol Dial Transplant; 2009 Sep; 24(9):2692-700. PubMed ID: 19376830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sodium selenosulfate at an innocuous dose markedly prevents cisplatin-induced gastrointestinal toxicity.
    Li J; Sun K; Ni L; Wang X; Wang D; Zhang J
    Toxicol Appl Pharmacol; 2012 Feb; 258(3):376-83. PubMed ID: 22172630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific antioxidant compounds differentially modulate cytotoxic activity of doxorubicin and cisplatin: in vitro and in vivo study.
    Panchuk R; Skorokhyd N; Chumak V; Lehka L; Omelyanchik S; Gurinovich V; Moiseenok A; Heffeter P; Berger W; Stoika R
    Croat Med J; 2014 Jun; 55(3):206-17. PubMed ID: 24891279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of the antioxidants alpha-tocopherol acetate and sodium selenite on hepatotoxicity induced by antitubercular drugs in rats.
    Kothekar MA; Ubaid RS; Jaju JB; Mateenuddin M
    Indian J Physiol Pharmacol; 2004 Jan; 48(1):119-22. PubMed ID: 15270380
    [No Abstract]   [Full Text] [Related]  

  • 52. [Antioxidant vitamins and selenium in the prevention of white muscle disease in calves].
    Kravtsiv RI; Stadnyk AM; Lychuk MH
    Ukr Biokhim Zh (1999); 2004; 76(4):90-9. PubMed ID: 19621762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of methylmercury and selenite on osmolarity and electrolytes in blood of mice.
    Yamamoto R; Suzuki T
    Toxicol Lett; 1982 Sep; 13(1-2):17-21. PubMed ID: 7179304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mechanism of interaction between cisplatin and selenite.
    Baldew GS; Mol JG; de Kanter FJ; van Baar B; de Goeij JJ; Vermeulen NP
    Biochem Pharmacol; 1991 May; 41(10):1429-37. PubMed ID: 2018551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma and erythrocyte Na, K, C1 and water in hypothermic and hyperthermic dogs.
    SPURR GB; BARLOW G
    Am J Physiol; 1959 Sep; 197():648-52. PubMed ID: 13833509
    [No Abstract]   [Full Text] [Related]  

  • 56. [Volume of extracellular fluids and of electrolytes in the plasma in kidney diseases].
    LATTANZI A; PANICHI S
    Minerva Nefrol; 1954; 1(2):64-75. PubMed ID: 13193765
    [No Abstract]   [Full Text] [Related]  

  • 57. [Electrolyte content of plasma and plasma and erythrocytes in nephrectomized rats. II].
    BRUNNER H; KUSCHINSKY G; PETERS G
    Klin Wochenschr; 1959 Sep; 37():926-8. PubMed ID: 13805335
    [No Abstract]   [Full Text] [Related]  

  • 58. Differences in plasma total base and cations in severe renal disease.
    TSAO MU; LEVINTHAL J
    Am J Med Sci; 1957 Dec; 234(6):696-701. PubMed ID: 13487578
    [No Abstract]   [Full Text] [Related]  

  • 59. Red cell electrolytes in patients with edema.
    KESSLER E; LEVY MR; ALLEN RL
    J Lab Clin Med; 1961 Jan; 57():32-41. PubMed ID: 13752740
    [No Abstract]   [Full Text] [Related]  

  • 60. Electrolyte alterations in human plasma and erythrocytes associated with chronic alcoholism.
    BARLOW G; WOOTEN RL
    Proc Soc Exp Biol Med; 1959 May; 101(1):44-6. PubMed ID: 13658185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.